Eli Lilly and Company announced that Johna Norton, executive vice president of Global Quality, will be retiring after 34 years of service with the company, effective July 31, 2024.
She will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee until her retirement date. An internal and external search is actively underway for her successor.
Norton has been with Lilly since 1990, starting as an analytical chemist and moving on to hold various leadership positions in quality assurance and quality control. She has supported research and development and commercial manufacturing at numerous Lilly facilities and with external manufacturing partners around the world. Norton played a key role in the successful transition of new molecules from development to manufacturing and the implementation of continuous manufacturing processes. As a quality leader at Lilly's Indianapolis and Ireland manufacturing facilities, she led work on the production of Lilly's first monoclonal antibodies for clinical trials and the build and qualification of the first monoclonal facility in Ireland. In 2017, Norton was named one of the Top Women in Life Sciences by FiercePharma.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!